Boston Biomedical has a number of oncology candidate drugs in development. Their leading drug is intended to treat gastric cancer, a tumor type of high unmet need. This means that because there are relatively few patients that contract this rare form of cancer there are a correspondingly few pharmaceutical companies developing drugs to treat it.

To help in achieving sales & marketing effectiveness Boston Biomedical employs Unifi to integrate dozens of data sets and uncover the target audience for their new drug. Bill Wallace, CIO at Boston Biomedical, explains why they use Unifi, “Unifi’s OneParse technology will help us extract insights from unstructured data sources and target sales activities far more quickly than ever before.”

Wallace likens the introduction of a new drug to a movie launch—how the movie performs in the first weekend is key to the future success of the title. And while drug promotion and sales take a little longer than a weekend, early adopters both on the clinical and patient side can make a world of difference to the success of a drug and the lives of the patients they treat.

Read the Case Study here